Question: Sree Chitra Tirunal Institute for Medical Sciences and Technology (SCTIMST) is located in which of the following state?
a) Tamil Nadu
b) Kerala
c) Maharashtra
d) Gujarat
Answer: (b)
Related Facts:
- India will soon have access to the country’s first indigenous flow diverter stent and the Nitinol-based occluder devices.
- The first device, a Flow Diverter stent is to be for diverting blood flow away from localized ballooning of arteries in the brain.
- Second set of devices is Nitinol-based occluder devices, which are presently used to heal Atrial Septal Defect (ASD) or hole in the heart.
- It should be known that Atrial Septal Defect (ASD) or hole in the heart is the condition that affects 8 out of every 1000 living babies born.
- Nitinol-based occluder devices are currently imported to meet the ASD treatment demands in India.
- At present India does not manufacture also flow diverters stents, which are needed for diverting blood flow away from an intracranial aneurysm or localized ballooning of arteries in the brain.
- Sree Chitra Tirunal Institute for Medical Sciences and Technology (SCTIMST) has took the initiative to manufacture these devices.
- SCTIMST is an autonomous institute of the Department of Science & Technology (DST), Govt. of India, under the Technical Research Centre (TRC).
- The institute has entered into Technology Transfer Agreements with Pune based Biorad Medisys for two these biomedical implant devices.
- These devices are Atrial Septal Defect Occluder and an Intracranial Flow Diverter Stents.
- SCTIMST is developing these devices in collaboration with National Aerospace Laboratories, Bangalore (CSIR-NAL) using superelastic NiTiNOL alloys.
- The Technology Transfer Agreements agreements were signed by Dr. K. Jayakumar, Director, SCTIMST, and Mr. Jitendra Hedge, Managing Director, Biorad Medisys.
By – Rajesh Tripathi
Link:-
https://pib.gov.in/Pressreleaseshare.aspx?PRID=1689298